Proactiveinvestors recommends

Additional Information

Market:	AIM
Sector:	Technology
EPIC:	SEE
Latest Price:	3.00 (0.00%)
52-week High:	3.88
52-week Low:	1.88
Market Cap:	12.41M

1 year chart

1 day chart

Seeing Machines Full Seeing Machines profile here

Seeing Machines (LON: SEE) is an award winning technology company with a focus on vision based human machine interfaces. Seeing Machines technology platform is based on world-leading computer vision processing technologies that allow machines to see and track human faces and certain facial features. These technologies enable the development of new cutting edge products and applications, ranging from devices that improve road safety & save lives, to those that help manage eye disease and prevent loss of eyesight.

The company’s focus is on deploying its computer vision technologies, worldwide, in:

Driver/operator safety products for transport markets through the DSS product range;
The TrueField Analyzer® (TFA) product for vision testing devices for healthcare markets;
New products in a range of markets including sports, entertainment, robotics and security through our faceAPI product; and
Human performance measurement through our faceLAB® product.

Seeing Machines reports maiden profit

Wednesday, September 24, 2008

Seeing Machines (AIM: SEE), the imaging software systems specialist, reported its maiden profit this morning in its full year results for the year ended 30 June 2008.

Financial Highlights included revenues up an impressive 55% to A$4.4 million, profits before tax leapt to A$0.327 million (2007: loss A$0.467 million) and earnings per share climbed to 0.11 cents (2007: loss per share of 0.18 cents). Seeing Machines also confirmed that at the end of the period it had cash reserves of A$2.77 million, double the level in the previous year.

Seeing Machines boosted its cash reserves after successfully raising A$3.2 million in October 2007 to assist in the continuing development, commercialisation and expansion of its products.

Of particular note, the group’s faceLAB product achieved its highest sales ever, of A$2.51 million during the financial year.

Fulton Muir, Chairman, stated:

“The 2008 financial year, with its significant revenue diversification and revenue growth along with our maiden profit was a tremendous result for the company and provides a strong foundation for our forward development. In the current financial year we are aiming to build on these recent successes with further strong sales of faceLAB® and the DSS and the launch of faceAPI and the TrueField® Analyzer'”

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.